Skip to content

Taxes Paid at other companies

Solventum logo
SolventumSOLV
$45.25M-25.8%
Merit Medical Systems logo
Merit Medical SystemsMMSI
$4.38M+15.8%
Novanta logo
NovantaNOVT
$4.49M-15.3%
BrightSpring Health Services, Inc. logo
BrightSpring Health Services, Inc.BTSG
$398K+62.4%
Boston Scientific logo
Boston ScientificBSX
$140.25M-14.5%
Medtronic logo
MedtronicMDT
$344M+13.2%

Other financials

Income statement

See full
Revenue$7.4B+10.7%
Gross profit$1.8B+0.9%
Operating income$422.0M-26.1%
Net income$239.0M-25.1%
EPS (diluted)$0.16

Balance sheet

See full
Cash & equivalents$2.2B+166%
Total debt$12.6B
Total equity$11.3B
Total assets$39.0B

Cash flow

See full
Operating cash flow$412.0M-39.6%
CapEx$96.0M-2.0%
Free cash flow$316.0M-45.9%

Valuation

See full
Market cap$33.35B+7.3%
Enterprise value$43.67B
P/E39.6×
P/S1.3×

Profitability

See full
Gross margin27.4%+1.5pp
Operating margin8.5%+2.3pp
Net margin4.6%+2.7pp
FCF margin6.4%+0.5pp

Returns & leverage

See full
Return on equity7.7%
Debt / equity1.1×
Current ratio4.4×

Where this comes from

Reported directly by Medline, Inc. in its filing.

Tagged under the XBRL concept us-gaap:IncomeTaxesPaidNet.

The official record: Medline, Inc. ’s 10-K, filed February 25, 2026, on SEC EDGAR. View the filing →

Ask your AI about Medline, Inc. 's taxes paid.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Medline, Inc. 's taxes paid?
Medline, Inc. (MDLN) reported taxes paid of $15.5M in Q4 2025.
How has Medline, Inc. 's taxes paid changed year-over-year?
Medline, Inc. 's taxes paid decreased by 38.6% year-over-year, from $25.25M to $15.5M.
What is the long-term trend for Medline, Inc. 's taxes paid?
Over 2 years (2023 to 2025), Medline, Inc. 's taxes paid has grown at a 9.2% compound annual growth rate (CAGR), from $52M to $62M.
What does taxes paid mean?
Actual cash paid to tax authorities for income taxes during the period — may differ from income tax expense due to timing.